Other Diseases of Blood and Blood-Forming Organs Recruiting Phase 1 / 2 Trials for Telaglenastat (DB15232)

Also known as: Disorder hematologic / Disorder blood (NOS) / Blood disorder NOS / Blood disorder / Blood/blood forming organ NOS / Dyscrasia blood (NOS) / Haematological disorders / Hematologic disorder / Hematologic Diseases / Diseases of blood and blood-forming organs, unspecified / Blood dyscrasia / Blood dyscrasia NOS / Disease of blood and blood-forming organs, unspecified / Unspecified diseases of blood and blood-forming organs / Diseases of blood and blood-forming organs, other

IndicationStatusPhase
DBCOND0082202 (Other Diseases of Blood and Blood-Forming Organs)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03047993Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromeTreatment